Literature DB >> 20825358

Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice.

Cesare Cuspidi1, Francesca Negri, Maria Lorenza Muiesan, Anna Capra, Laura Lonati, Alberto Milan, Carla Sala, Marcella Longo, Alberto Morganti.   

Abstract

BACKGROUND AND AIM: The prevalence of left ventricular hypertrophy (LVH) in human hypertension has been mostly documented in population-based samples and selected hypertensive cohorts. Rather scant data are available from clinical practice. Thus, we examined the prevalence of LVH in a large group of hypertensive patients referred by general practitioners to a routine echocardiographic examination.
METHODS: A total of 2249 hypertensive subjects (mean age 62 years, 52.3% men, 84.5% treated) referred by their practitioners to 17 outpatient echocardiographic laboratories across Italy for detection of hypertensive early cardiac damage were included in the study. LVH was defined as left ventricular mass (A) ≥ 225/163 g, (B) ≥ 116/96 g/m(2), (C) ≥ 49/45 g/m(2.7) in men/women, respectively; LVH was graded as mild, moderate and severe according to Lang's report.
RESULTS: Overall, patients with LVH were 58%, 58% and 65% by criteria A, B and C, respectively. LVH was mild in 33% (A), 36% (B) and 29% (C), moderate in 31% (A), 28% (B) and 27% (C), and severe in 36% (A), 36% (B) and 44% (C).
CONCLUSIONS: Data provided by this multicentre nationwide survey support the view that, despite therapeutic interventions, LVH remains a highly frequent phenotype in human hypertension and that severe LVH is present in a large fraction of hypertensives.

Entities:  

Mesh:

Year:  2010        PMID: 20825358     DOI: 10.3109/08037051.2010.514713

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  6 in total

Review 1.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

2.  Cardiovascular Hypertension-Mediated Organ Damage in Hypertensive Urgencies and Hypertensive Outpatients.

Authors:  Fabrizio Vallelonga; Marco Cesareo; Leonardo Menon; Lorenzo Airale; Dario Leone; Anna Astarita; Giulia Mingrone; Maria Tizzani; Enrico Lupia; Franco Veglio; Alberto Milan
Journal:  Front Cardiovasc Med       Date:  2022-05-16

3.  Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.

Authors:  Gari Negeri Jaleta; Esayas Kebede Gudina; Wondim Getinet
Journal:  BMC Res Notes       Date:  2014-01-20

4.  A review of echocardiograms in hypertensive patients greater than 60 years in a community based family medicine program.

Authors:  Shideh Doroudi; Michael D DeLisi; Vincent A DeBari
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-03-31

5.  Left ventricular mass formulae and prevalence rates of echocardiographic left ventricular hypertrophy in nigerians with essential hypertension.

Authors:  Ebenezer Adekunle Ajayi; Ajayi Ebenezer Adekunle; Iyiade Adeseye Ajayi; Ajayi Iyiade Adeseye; Tolulope Adebayo Oyedeji; Oyedeji Tolulope Adebayo; Adekunle Olatayo Adeoti; Adeoti Adekunle Olatayo; Olusola Joseph Omotoye; Omotoye Olusola Joseph; Rasaaq Ayodele Adebayo; Adebayo Rasaaq Ayodele
Journal:  N Am J Med Sci       Date:  2013-05

6.  Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers.

Authors:  Monika Możdżan; Karina Wierzbowska-Drabik; Małgorzata Kurpesa; Ewa Trzos; Tomasz Rechciński; Marlena Broncel; Jarosław D Kasprzak
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.